You have no items in your shopping cart.
- Human VEGF 121 [orb2994925]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 14.2 KDa. Observed: 16 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human VEGF 121 [orb2994931]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 90% as determined by SEC-HPLC.(QC verified)
Predicted: 15.1 KDa. Observed: 16-18 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human VEGF-D [orb2995034]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 13 KDa. Observed: 18 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human VEGF-C [orb2995003]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 85% as determined by SEC-HPLC.(QC verified)
Predicted: 23.27 KDa. Observed: 25-30 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human VEGFA Protein, His Tag [orb757432]Featured

Unconjugated
The purity of the protein is greater than 95% as determined by SDS-PAGE and Coomassie blue staining.
The protein has a predicted molecular mass of 14.8 kDa after removal of the signal peptide.
Mammalian
50 μg, 100 μg, 10 μg - Featured
Active> 96 % by SDS-PAGE and HPLC analyses.
Approximately 11.5 kDa, a single non-glycosylated polypeptide chain containing 98 amino acids.
Escherichia coli
5 μg, 100 μg, 500 μg - Human VEGF 165 protein [orb178366]
SDS-PAGE
Unconjugated
> 85% as determined by SDS-PAGE
0.5 mg, 1 mg, 0.1 mg









